Singapore markets closed

CV Sciences, Inc. (CVSI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0540+0.0050 (+11.36%)
As of 10:14AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0490
Open0.0480
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0480 - 0.0540
52-week range0.0300 - 0.0600
Volume48,289
Avg. volume269,883
Market cap8.814M
Beta (5Y monthly)0.55
PE ratio (TTM)2.70
EPS (TTM)0.0200
Earnings date14 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2024, before the stock market opens on Tuesday, May 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) tha

  • Insider Monkey

    CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript

    CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript March 28, 2024 CV Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences’ Fourth Quarter and Year-End 2023 Conference. At this time, all participants are […]

  • PR Newswire

    CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

    CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.